Beacon Harbor Wealth Advisors, Inc. Abb Vie Inc. Transaction History
Beacon Harbor Wealth Advisors, Inc.
- $409 Million
- Q3 2025
A detailed history of Beacon Harbor Wealth Advisors, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Beacon Harbor Wealth Advisors, Inc. holds 34,976 shares of ABBV stock, worth $8.18 Million. This represents 1.98% of its overall portfolio holdings.
Number of Shares
34,976
Previous 34,803
0.5%
Holding current value
$8.18 Million
Previous $6.46 Million
25.36%
% of portfolio
1.98%
Previous 1.67%
Shares
25 transactions
Others Institutions Holding ABBV
# of Institutions
4,492Shares Held
1.28BCall Options Held
16.9MPut Options Held
15.2M-
Vanguard Group Inc Valley Forge, PA178MShares$41.6 Billion0.64% of portfolio
-
Black Rock Inc. New York, NY136MShares$31.9 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.8MShares$18.7 Billion0.66% of portfolio
-
Jpmorgan Chase & CO New York, NY56.5MShares$13.2 Billion0.86% of portfolio
-
Morgan Stanley New York, NY41.7MShares$9.75 Billion0.61% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $414B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...